ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAA3.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $495,000 | -21.9% | 500,000 | 0.0% | 0.22% | -14.0% |
| Q2 2015 | $634,000 | +0.6% | 500,000 | 0.0% | 0.25% | +1.2% |
| Q1 2015 | $630,000 | -32.9% | 500,000 | -50.0% | 0.25% | -32.7% |
| Q4 2014 | $939,000 | +107.7% | 1,000,000 | +100.0% | 0.37% | +106.2% |
| Q3 2014 | $452,000 | -9.8% | 500,000 | 0.0% | 0.18% | -7.8% |
| Q2 2014 | $501,000 | -3.1% | 500,000 | 0.0% | 0.19% | -5.9% |
| Q1 2014 | $517,000 | -1.0% | 500,000 | 0.0% | 0.20% | -3.3% |
| Q4 2013 | $522,000 | -69.8% | 500,000 | -66.7% | 0.21% | -70.7% |
| Q3 2013 | $1,730,000 | +20.6% | 1,500,000 | 0.0% | 0.72% | +14.8% |
| Q2 2013 | $1,435,000 | – | 1,500,000 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 45,000,000 | $53,278,000 | 2.48% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,000,000 | $6,018,000 | 0.85% |
| CSS LLC/IL | 10,546,000 | $12,816,000 | 0.62% |
| Verition Fund Management LLC | 3,400,000 | $4,025,000 | 0.43% |
| Redmile Group, LLC | 4,000,000 | $4,761,000 | 0.38% |
| OAKTREE CAPITAL MANAGEMENT LP | 19,600,000 | $23,231,000 | 0.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,139,000 | $13,378,000 | 0.20% |
| LINDEN ADVISORS LP | 2,000,000 | $2,374,000 | 0.11% |
| Fernwood Investment Management, LLC | 90,000 | $106,000 | 0.10% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 5,000,000 | $5,909,000,000 | 0.09% |